Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment

Evaluation of cancer therapy with imaging is crucial as a surrogate marker of effectiveness and survival. The unique response patterns to therapy with immune-checkpoint inhibitors have facilitated the revision of response evaluation criteria using FDG-PET, because the immune response recalls reactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Oriuchi, Noboru, Endoh, Hideki, Kaira, Kyoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409366/
https://www.ncbi.nlm.nih.gov/pubmed/36012657
http://dx.doi.org/10.3390/ijms23169394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409366/
https://www.ncbi.nlm.nih.gov/pubmed/36012657
http://dx.doi.org/10.3390/ijms23169394

Ejemplares similares